Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Tvardi Therapeutics (TVRD) vs. Competitors

2,531 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
TVRDTvardi Therapeutics$1.10$14.70M-0.42-72.70%Moderate BuyUnlock the TVRD analyst price target with TipRanks PremiumTVRDUnlock the TVRD top-analyst price target with TipRanks Premium
CUECue Biopharma$14.10$102.43M-0.53-25.40%Moderate BuyUnlock the CUE analyst price target with TipRanks PremiumTVRD vs CUEUnlock the CUE top-analyst price target with TipRanks Premium
ALGSAligos Therapeutics$1.66$11.70M-0.26-75.08%Moderate BuyUnlock the ALGS analyst price target with TipRanks PremiumTVRD vs ALGSUnlock the ALGS top-analyst price target with TipRanks Premium
ANLAdlai Nortye Ltd. Sponsored ADR$10.03$645.91M-5.14542.95%Strong BuyUnlock the ANL analyst price target with TipRanks PremiumTVRD vs ANLUnlock the ANL top-analyst price target with TipRanks Premium

Performance Comparison

-250%0%250%500%750%1000%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
TVRDTvardi Therapeutics1.10-2.93-72.70%
CUECue Biopharma14.10-3.12-18.12%
ALGSAligos Therapeutics1.66-5.36-76.35%
ANLAdlai Nortye Ltd. Sponsored ADR10.038.46538.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts